Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 149.37

-4.5%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harvey Allen who wrote (385)	1/7/2008 11:13:52 AM
From: Bob Laz	Read Replies (1) of 395

Close today over $6.12 would be great - recover over next week or two and onward and upward. HOPEFULLY WE GET SOMETHING LIKE SECRETIN FAST TRACK APPROVAL - ACQUIRE A GREAT PATENT OF COMPANY - OR MOST OF ALL: WE ARE ACQUIRED BY A BIG PHARMA FOR $12 - $15 - slim but its happened and again the bipolar market is a big trump card due to its size - GO URIDINE! Would big pharma bet on Uridine as part of the upside in addition to CTLA4 / Orencia?? Why not if the package / RGEN only cost $12 x 31M = $372M - how about $10 a share for $31M purchase price and another $80M / or additional shares if Uridine is passes next FDA P2.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next